LeafCann’s mission is to advance the re-introduction of plant-based extracts in medicine and nutrition through conducting and supporting product and industry research and development, clinical trials, commercial production and GMP manufacturing.
LeafCann is building a robust and agile Medicinal Cannabis supply chain, forging export agreements and working towards ensuring patients have access to precision cannabis medicines made from the highest quality ingredients at affordable prices. With a world-class management team and leading international professionals on our advisory board, LeafCann is well placed to execute this mission globally. LeafCann is ready to be one of this Australia’s pioneering Medicinal Cannabis producers. Developing state-of-the-art in-door controller- grow facilities using high-tech chambers and Supercritical CO2 (SCCO2) extraction, LeafCann aims to produce stable, consistent, extracts and Activated Pharmaceutical Ingredients from the cannabis plant, for use in clinical trials and Special Access Schemes. On a global stage, Australia has the opportunity to take a leading role in the development of medicinal cannabis through its reputation as an innovative country with a strong heritage in medical research, product development, and agriculture. Perhaps the greatest positive for Medicinal Cannabis is the overwhelming support of the Australian public.